Dimitrios C. Ziogas

Catechol-O-Methyltransferase val158met Polymorphism Predicts Placebo Effect in Irritable Bowel Syndrome

Kathryn T. Hall, Anthony Lembo, Irving Kirsch et al. · PLoS ONE · 2012 · 202 citations · Full text

Pain Disorders, Placebo Response, Health Sciences +13

Cardiac and renal complications of carfilzomib in patients with multiple myeloma

Meletios Α. Dimopoulos, Maria Gavriatopoulou, Erasmia Psimenou et al. · Blood Advances · 2017 · 104 citations · Full text

Predicting the Outcome of Sjogren’s Syndrome-Associated Non-Hodgkin’s Lymphoma Patients

Dimitrios C. Ziogas, Clio P. Mavragani, Athanasios G. Tzioufas et al. · PLoS ONE · 2015 · 92 citations · Full text

Bortezomib‐based triplets are associated with a high probability of dialysis independence and rapid renal recovery in newly diagnosed myeloma patients with severe renal failure or those requiring dialysis

Meletios Α. Dimopoulos, Maria Gavriatopoulou, Erasmia Psimenou et al. · American Journal of Hematology · 2016 · 91 citations · Full text

Evaluation of the Revised International Staging System in an independent cohort of unselected patients with multiple myeloma

Efstathios Kastritis, Evangelos Terpos, Maria Gavriatopoulou et al. · Haematologica · 2016 · 86 citations · Full text